E7: The Outlook for Pharmaceuticals to 2012

Table of Contents

BRAZIL BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • GDP, 2000-2011
• POPULATION
  • Population, 2000-2011
  • Population by Age Group, July 2000-July 2010 (Million)
  • Population by Region, July 2005-July 2006
• DEMOGRAPHIC INDICATORS
  • Reported Demographic Indicators, 2000-2004
  • Estimated Demographic Indicators, 2000-2007
• MORTALITY
  • Deaths by Selected Cause, 2000-2004
  • Deaths by Selected Cause, 2000-2004 (%)
  • Change in Deaths by Selected Cause, 2000-2004 (%)
  • Detailed Causes of Death, 2004
• Infant Mortality
  • Infant Mortality by Cause, 1999-2004
• MORBIDITY
  • Notified Infectious Diseases, 1999-2005
  • Notified Infectious Diseases, 1999-2005 (%)
  • Change in Notified Infectious Diseases, 1999-2004 (%)
• AIDS
  • Notified Cases of AIDS by Region, 1980-2005
  • Notified Deaths by AIDS, 1980-2004
• Cancer
  • Estimated Cancer Incidence by Site, 2005
• Anaemia

CHARTS

• Map of Brazil
• Notified Deaths by AIDS, 1980-2004 (000)

BRAZIL HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
  • Ministry of Health' s Organisation, 2006
• HEALTH EXPENDITURE
  • Estimated Health Expenditure, 2003-2012 (US$ Billion)
  • Estimated Health Expenditure by Sector, 2000-2003 (%)
• Public Health Expenditure
  • Public Health Expenditure as % of GDP by Sector, 2000-2003
  • Public Health Expenditure by Sector, 2000-2003 (R$ Billion)
  • Public Health Expenditure by Sector, 2000-2003 (%)
  • Per Capita Public Health Expenditure by Sector, R$ (2000-2003)
  • Public Health Expenditure by Sector & Region, 2003 (R$ Billion)
  • Public Health Expenditure by Sector & Region, 2003 (%)
• HEALTHCARE ESTABLISHMENTS
  • Healthcare Establishments, 1985-2005
  • Healthcare Establishments by State, 1985-2005
  • Healthcare Establishments by Activity & Sector, 1985-2005
  • Healthcare Establishments by Activity & Sector, 1985-2005 (%)
  • Healthcare Establishments by Sector, 1985-2005
  • Healthcare Establishments by State & Sector, 2005
  • Healthcare Establishments by Region & Sector, 2005 (%)
  • Healthcare Establishments by Region & Activity, 2005
  • Healthcare Establishments by Region & Type, 2005
  • Public Healthcare Establishments by Region & Type, 2005
  • Private Healthcare Establishments by Region & Type, 2005
  • Private/SUS Healthcare Establishments by Region & Type, 2005
  • Healthcare Establishments by Region & Level of Contracted Services, 2005
• HOSPITAL SERVICES
  • Healthcare Establishments with Inpatient Facilities by Sector, 1985-2005
  • Healthcare Establishments with Inpatient Facilities by Sector & Region, 2005
  • Healthcare Establishments with Inpatient Facilities by Type & Region, 2005
  • Specialist Healthcare Establishments with Inpatient Facilities by Sector & Region, 2005
  • Healthcare Establishments with Inpatient Facilities, with Specialities, by Sector & Region, 2005
  • General Healthcare Establishments with Inpatient Facilities by Sector & Region, 2005
• SUS Hospitals
  • SUS Establishments with Inpatient Facilities by Sector & Provider, 1997-2003
  • SUS Establishments with Inpatient Facilities by State & Sector, July 2003
• Hospital Beds
  • Hospital Beds by Sector, 1985-2005
  • Hospital Beds by Sector, 1985-2005 (%)
  • Change in Hospital Beds by Sector, 1985-2005 (%)
  • Summary of Hospital Beds by Sector & Region, 2005
  • Summary of Hospital Beds by Sector & Region, 2005 (%)
  • Change in Hospital Beds by Sector & Region, 2002-2005 (%)
  • Hospital Beds by Sector & State, 2005
  • Summary of SUS Hospital Beds by Sector & Region, 2005
  • Summary of SUS Hospital Beds by Sector & Region, 2005 (%)
  • Change in SUS Hospital Beds by Sector & Region, 2002-2005 (%)
  • Hospital Beds by Sector & State, July 2003
  • Hospital Beds by Sector & Speciality, July 2003
  • Hospital Beds by Speciality, 1992-2003
• Hospital Activity
  • Summary of Hospital Admissions by Sector & Region, 2004
  • Summary of Hospital Admissions by Sector & Region, 2004 (%)
  • Change in Hospital Admissions by Sector & Region, 2001-2004 (%)
  • Hospital Admissions by Sector & State, 2004
  • SUS Hospital Admissions by Sector, 2000-2005
  • SUS Hospital Admissions by Sector, 2000-2005 (%)
  • SUS Hospital Admissions by Speciality, 2000-2005
  • SUS Hospital Admissions by Speciality, 2000-2005 (%)
  • Change in SUS Hospital Admissions by Speciality, 2000-2005 (%)
  • SUS Hospital Admissions by Cause Group, 2002-2003
  • SUS Hospital Admissions by Cause Group, 2002-2003 (%)
  • SUS Hospital Inpatients by Cause, 2003
• AMBULATORY CARE
  • Healthcare Establishments with Ambulatory Care by Type & Region, 2005
  • Healthcare Establishments with Ambulatory Care by Type & Region, 2005 (%)
  • Healthcare Establishments with Emergency Services by Region & Specialty, 2005
  • Healthcare Establishments with Emergency Services by Region & Specialty, 2005 (%)
  • Healthcare Establishments with Emergency Services by Specialty, 2005 (%)
  • Healthcare Establishments with Ambulatory & Hospital Care by Sector & Specialty, 2005
  • SUS Ambulatory Network by Type, 2001-2003
  • SUS Ambulatory Network by Type & Region, July 2003
  • SUS Ambulatory Network by Type & Region, July 2003 (%)
  • SUS Outpatient Facilities by Type, 2001-2003
  • SUS Outpatient Facilities by Provider, 2001-2003
• Ambulatory Activity
  • SUS Ambulatory Activity by Region, 1997-2005
  • Summary of SUS Ambulatory Activity by Type of Procedure, 2000-2004 (Billion)
  • Summary of SUS Ambulatory Activity by Type of Procedure, 2000-2004 (%)
  • SUS Ambulatory Activity by Provider, 2003 & 2004
  • SUS Ambulatory Activity by Type of Procedure, 2000-2004
• Second Disease Surveillance & Control Project
• Bahia Health System Reform Project
• Family Health Extension Programme
• MEDICAL EQUIPMENT
  • Healthcare Establishments with Diagnostic & Therapy Services by Sector & Specialty, 2005
  • Healthcare Establishments with Inpatient Facilities by Sector, Type of Service & Equipment, 2005
  • Healthcare Establishments Without Inpatient Facilities by Sector, Type of Service & Equipment, 2005
  • Summary of Medical Equipment, 2005
  • Summary of Medical Equipment by Type of Provider, 2002
  • Summary of Medical Equipment by Type of Provider, 2002 (%)
  • Summary of Medical Equipment by Sector, 2005
  • Summary of Medical Equipment by Sector & Type of Provider, 2002
  • Summary of Medical Equipment by Sector & Type of Provider, 2002 (%)
  • Diagnostic Equipment by Type, 2002-2005
  • Diagnostic Equipment by Region, 2002-2005
  • Diagnostic Equipment by Sector & Type, 2005
  • Diagnostic Equipment by Sector & Region, 2005
  • Optical Equipment by Type, 2002-2005
  • Optical Equipment by Region, 2002-2005
  • Optical Equipment by Sector & Type, 2005
  • Optical Equipment by Sector & Region, 2005
  • Graphical Equipment by Type, 2002-2005
  • Graphical Equipment by Region, 2002-2005
  • Graphical Equipment by Sector & Region, 2005
  • Radiotherapy Equipment, 2002-2005
  • Radiotherapy Equipment by Region, 2002-2005
  • Radiotherapy Equipment by Sector & Region, 2005
  • Life Support Equipment by Type, 2002-2005
  • Life Support Equipment by Region, 2002-2005
  • Life Support Equipment by Sector & Type, 2005
  • Life Support Equipment by Sector & Region, 2005
  • Other Medical Equipment by Sector & Type, 2005
  • Other Medical Equipment by Sector & Region, 2005
• MEDICAL PERSONNEL
  • Summary of Health Personnel, 2002-2005
  • Summary of Health Professionals by Region, 2005
  • Summary of Health Professionals by Region, 2005 (%)
  • Change in Health Professionals by Region, 2002-2005 (%)
  • Summary of Health Professionals by Sector, 2005
  • Summary of Health Professionals by Sector, 2005 (%)
  • Change in Health Professionals by Sector, 2002-2005 (%)
  • Summary of Health Professionals by Region & Sector, 2005
  • Summary of Health Assistants & Technicians by Region, 2005
  • Summary of Health Assistants & Technicians by Sector, 2005
  • Medical Personnel by Occupation, 2002
  • Medical Personnel by Sector & Occupation, 2002
  • Change in Medical Personnel by Occupation, 1999 & 2002

CHARTS

• Healthcare Establishments, 1985-2005
• Healthcare Establishments by Sector, 1985-2005
• Healthcare Establishments by Region, 2005 (%)
• Healthcare Establishments by Sector, 2005 (%)
• Healthcare Establishments by Region & Activity, 2005 (%)
• Healthcare Establishments by Sector & Type, 2005
• Healthcare Establishments by Region & Type, 2005
• Healthcare Establishments by Region & Level of Contracted Services, 2005 (%)
• SUS Hospital Admissions by Sector, 1995-2004 (Million)
• Healthcare Establishments with Ambulatory Care by Type & Region, 2005
• SUS Ambulatory Activity, 1997-2004 (Billion)
• Diagnostic & Therapy Services by Sector & Specialty, 2005 (%)
• Summary of Medical Equipment, 2005
• Summary of Medical Equipment, 2002-2005
• Summary of Medical Equipment by Sector, 2005
• Doctors, 1992-2005
• Summary of Health Professionals by Region, 2005
• Health Professionals by Sector, 2005
• Summary of Health Professionals by Region & Sector, 2005

BRAZIL ACCESSING THE PHARMACEUTICAL MARKET

• TABLE OF CONTENTS
• INTRODUCTION
• REGULATORY ENVIRONMENT
• MERCOSUR Regulation
• National Regulation
• Registration
  • Exemptions
• Imports
• Clinical Trials
• Labelling & Packaging
• Quality Control
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing
  • Drug Price Adjustments, 2003-2006 (%)
  • Implications for the industry
  • Excessive taxes on drugs
• DISTRIBUTION CHANNELS
• Distributors
  • Members of ABAFARMA, 2006
  • Distribuidora Farmacêutica Panarello
  • Profarma
  • Profarma' s Operational Indicators, 2003-2006
  • Profarma' s Distribution Centres, 2006
  • Profarma' s Gross Sales, 2003-2006 (R$ Million)
  • Profarma' s Gross Sales, 2003-2006 (US$ Million)
  • Profarma' s Leading Pharmaceutical Suppliers, 2005
  • Distribuidora Santa Cruz
• Pharmacies
  • Regulation
  • Farmácia Popular do Brasil
• Pharmacy & Drugstore Chains
  • ABRAFARMA
  • Members of ABRAFARMA, 2006
  • FEBRAFAR
  • Members of FEBRAFAR by Region, 2006
  • ASSIFARMA
  • ASCOFERJ
• TRADE FAIRS
• ABRADILAN FARMA
• ECONOFARMA
• EXPO PHARMA
• FARMA RACINE EXPO
• FCE PHARMA
• FEIRAFARMA
• Hospitalar
• DOMESTIC PRODUCTION
  • Gross Production, 1996-2004
  • Gross Production by Leading State, 1996-2004 (R$ Million)
  • Workforce, 1996-2004
• Trade Associations
  • ABIMIP
  • Members of ABIMIP, 2006
  • ALANAC
  • Members of ALANAC, 2006
  • ALFOB
  • Members of ALFOB, 2006
  • FEBRAFARMA
  • Members of FEBRAFARMA, 2006
  • INTERFARMA
  • Members of INTERFARMA, 2006
  • Pró-Genéricos
  • Members of Pró-Genéricos, 2006
• Domestic Producers
  • Aché
  • Aché' s & Biosintética' s Gross Revenues by Therapeutic Areas, 2005
  • Therapeutic Areas Covered by Aché & Biosintética, 2005
  • Aché' s Leading Products by Therapeutic Area, 2005
    • Biosintética
  • Biosintética' s Sales, 2001-2004
  • Biosintética' s Pharmaceutical Sales by Therapeutic Areas, 2004
  • Barrenne Industria Farmacêutica
  • Barrenne' s Leading Products, 2005
  • Biolab
  • Cimed
  • Cristália' s Business Units, 2006
  • Cristália' s International Representatives, 2006
  • EMS-SIGMA PHARMA
  • Eurofarma
  • Farmasa
  • JP Indústria Farmacêutica
  • Libbs Farmacêutica
  • Libbs' Pharmaceutical Sales, 2000-2006
  • Medley
  • Medley' s International Agreements, 1992-2005
  • Nortec Química
  • Teuto
  • Vitapan
• Multinational Activity
  • Abbott
  • Allergan
  • Altana
  • AstraZeneca
  • Bayer-Schering
    • Bayer
    • Schering
  • Boehringer Ingelheim
  • Boehringer Ingelheim' s Financial Data, 2002-2005
  • BI' s Leading Product Launches, 2000-2005
  • Bristol-Myers Squibb
  • Eli Lilly
  • Farmalab Chiesi
  • GlaxoSmithKline
  • Merck
  • Merck Sharp & Dohme
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Sanofi-Aventis' s Launched Pharmaceuticals, 2005
  • Schering Plough
  • Wyeth
• Research & Development
  • 2004-2007 National Industrial Policy
  • Demands by Domestic Pharmaceutical Producers to the Ministry of Science & Technology, 2005
  • Profarma & Progeren
  • Profarma' s Objectives, 2005
• DIRECTORY
• Government Organisations
• Trade Associations

CHARTS

• Gross Production, 1996-2004
• Change in Gross Production, 1997-2004 (%)
• Production by Leading State, 2004 (%)
• Number of Producers, 1996-2004
• Workforce by Leading State, 2004 (%)
• Workforce, 1996-2004
• Aché' s & Biosintética' s Gross Turnover & Number of Products, 2005
• Aché' s Gross Revenues, 2001-2005 (R$ Million)
• Aché' s Gross Revenues, 2001-2005 (US$ Million)
• Biosintética' s Sales, 2001-2004
• Libbs' Pharmaceutical Sales, 2000-2006
• Pfizer' s Projected Sales, 2005-2007

INDIA BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
• POPULATION
  • Population by States and Territories, 2001-2006
• DEMOGRAPHIC INDICATORS
  • Demographic Indicators, 1995-2005
  • Demographic Indicators by State, 2005
• MORTALITY
  • Major Causes of Death, Rural India 1993-1998
  • Deaths from Non-Communicable Diseases, 1998
• MORBIDITY
• National Rural Health Mission
• Child Survival and Safe Motherhood
  • Reproductive and Child Health Programme
  • Woman & Child Development Project
  • Universal Immunisation Programme
    • Reported Incidence of Vaccine Preventable Diseases, 1985-2000
  • Reducing Fertility
    • Family Planning
    • All India Hospitals Post-Partum Programme
• National Health Programmes for Disease Control/Eradication
  • National Vector Borne Disease Control Programme
    • Malaria
      • Reported Malaria Incidence & Deaths, 1990-2004
    • Filariasis
    • Kala-azar
      • Reported Kala-azar Cases & Deaths, 1996-2004
    • Japanese Encephalitis
      • Suspected Japanese Encephalitis Cases & Deaths, 2000-2005
  • National Programme for the Control of Blindness
  • National Leprosy Eradication Programme
  • National Tuberculosis Control Programme
  • HIV/AIDS
  • National AIDS Control Programme
  • Cancer

CHARTS

• Map of India
• Population by Age Group, 2006 (%)

INDIA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• The Department of Health
• The Department of Family Welfare
• The Department of Indian Systems of Medicine & Homeopathy
• Health Insurance
  • Apollo Family Health Plan
• HEALTH EXPENDITURE
  • Health Expenditure by Source of Funds, 2001/02
  • Department of Health Budget Allocations, 2004-2006
  • MoHFW Health Expenditure by Scheme, 2004/05
• HOSPITAL SERVICES
• Hospital Resources
  • Hospitals & Beds by State & Sector, 2002
  • Government Hospitals/CHCs and Beds by State, 2006
  • Hospitals, Dispensaries & Beds, 1991-1998
  • Beds in Selected Hospitals, 2001/02
• All India Institute of Medical Sciences (AIIMS)
  • AIIMS Hospital Beds, 1999/2000
  • AIIMS Hospital Beds by Specialty, 1999/2000
  • AIIMS Hospital Activity, 1999/2000
• Safdarjung Hospital, New Delhi
  • Safdarjung Hospital Beds by Specialty, 2003
• Dr. Ram Manohar Lohia Hospital, New Delhi
  • Dr. Ram Manohar Lohia Hospital Beds by Specialty, 2000/01
• JIPMER Hospital, Pondicherry
  • JIPMER Hospital Beds by Specialty, 2000
• PGIMER Nehru Hospital, Chandigarh
  • PGIMER Nehru Hospital Beds by Specialty, 2001/02
• Lady Hardinge Medical College Associated Hospitals, New Delhi
• Private Hospitals and Clinics
  • Apollo Hospitals Group
  • Fortis Healthcare
  • Max Healthcare
  • Other Commercial Providers
• AMBULATORY CARE
  • Sub-centres and Primary Health Centres, 2004-2005 (September)
  • CGHS Out-patient Facilities, 31st March 2005
• First Aid and Disaster Relief
  • St. John Ambulance
  • Indian Red Cross Society
• Healthcare for the Underprivileged, Scheduled Castes and Scheduled Tribes
  • Healthcare Infrastructure in Tribal/Scheduled Caste Areas, 1995-2005
• Medical Care for Remote & Marginalised Tribal & Nomadic Communities
• MEDICAL PERSONNEL
  • Doctors Registered with State Medical Councils, 1995-2004
  • Registered Dental Surgeons, 1994-2004
  • Registered Nursing Personnel, 1994-2004
  • Healthcare Personnel in Rural Areas, 1998-2005

CHARTS

• Health Expenditure by Source, 2001/02 (%)
• Department of Health Budget Allocation by Segment, 2005/06 (%)

INDIA ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• National Pharmaceuticals Policy 2006
• Pharmaceutical Registration
• Advertising
• Patent Protection & Intellectual Property Rights
  • Background to Pharmaceutical Patents
  • Mashelkar Committee Report, December 2006
  • The Patents (Amendments) Bill, 2005
    • Compulsory Licensing
    • Pre- & Post-Grant Opposition
    • Mailbox Applications
    • Other Issues
  • The Patents (Amendment) Rules 2006
  • Previous Patents Act Amendments and Exclusive Marketing Rights
    • Glivec/Gleevec Patent Setback for Novartis
• Pricing
  • Drugs (Prices Control) Amendment Order and Second Amendment Order, 2006
  • Price Reductions
  • Drug Price Control Review Committee
• DISTRIBUTION CHANNELS
  • Medical Stores Organisation
• TRADE FAIRS
  • Pharma + Biotech World Expo 2007
  • India Pharma 2006
• DOMESTIC PRODUCTION
  • Global Sales by Leading Domestic Companies, 2005/06
• BCG Vaccine Laboratory, Chennai (Madras)
• Trade Associations
• Domestic Producers
  • Alembic Ltd
    • Alembic Financial Results, 2003-2006
  • Aurobindo Pharma
    • Aurobindo Pharma' s ANDA Approvals, 2004-2007
    • Aurobindo Pharma Financial Results, 2003-2006
  • Biocon
    • Biocon Financial Results, 2003-2006
  • Blue Cross Laboratories Ltd
  • Cipla Ltd
    • Cipla Financial Results, 2003-2006
  • Dr. Reddy' s Laboratories Ltd
    • Dr Reddy' s Laboratories ANDA approvals, 2002-2006
    • Dr Reddy' s Financial Summary, 2003-2006
  • Lupin Limited
    • Lupin' s ANDA approvals, 2003-2006
    • Lupin Financial Results, 2003-2006
  • Natco Pharma
    • Natco Pharma Financial Results, 2003-2006
  • Nicholas Piramal India Ltd
    • NPIL Financial Results, 2003-2006
  • Orchid Chemicals & Pharmaceuticals Ltd
    • Orchid' s Top-10 Brands
    • Orchid' s ANDA Approvals, 2005-2006
    • Orchid Financial Results, 2003-2006
  • Ranbaxy Laboratories Ltd
    • Ranbaxy' s Top 10 Molecules (US$ Million)
    • Ranbaxy Laboratories ANDA approvals 2002-2006
    • Ranbaxy Financial Results, 2003-2006
  • Sun Pharmaceutical Industries Ltd
    • Sun Pharma ANDA Approvals, 2006-2007
    • Caraco Pharmaceutical ANDA Approvals, 2002-2006
    • Sun Pharma Financial Results, 2003-2006
  • Wockhardt Ltd
    • Wockhardt' s ANDA Approvals, 2003-2006
    • Wockhardt Financial Results, 2003-2005
  • Zydus Cadila
    • Zydus' ANDA Approvals, 2005-2007
    • Zydus Cadila Financial Results, 2003-2006
    • Domestic Formulation Sales by Therapy Area, 2006
  • Multinational Activity
  • Actavis
  • GlaxoSmithKline
  • Pfizer India
  • sanofi-aventis
• Research & Development
  • New Millennium Indian Technology Leadership Initiative
  • Indian Council of Medical Research
  • Central Research Institute, Kasauli
  • Central Drug Research Institute, Lucknow
  • Central Council for Research in Unani Medicine
  • Central Council for Research in Ayurveda and Siddha
  • Central Council for Research in Homeopathy
• Traditional Indian Medicines
  • Components
  • Ayurvedic Supply
• DIRECTORY
• Government Organisations
• Trade Associations

CHARTS

• Cipla Exports by Geographic Area, 2006 (%)
• Dr Reddy' s Sales by Geographic Area, 2006 (%)
• Orchid API Sales by Region, 2006 (%)
• Orchid Formulations Sales by Region, 2006 (%)
• Wockhardt Sales by Region, 2005 (%)

MEXICO BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • GDP, 2006-2011
• POPULATION
  • Projected Population, 2006-2011
  • Projected Population Aged 65 Years and Over, 2006-2011
  • Estimated Population by Age Group, 2001-2005 (000)
  • Estimated Population by Age Group, 2001-2005 (%)
  • Change in Estimated Population by Age Group, 2001-2005 (%)
  • Estimated Population by State, 2005
• DEMOGRAPHIC INDICATORS
  • Demographic Indicators, 2000-2004
• MORTALITY
  • Leading Causes of Death, 1990-2004 (%)
  • Leading Causes of Death by Sex, 2004 (%)
  • Reported Causes of Death, 2000
• Infant Mortality
  • Infant Mortality by Cause, 1990-2004
• MORBIDITY
  • Selected Reportable Diseases, 2003-2005
  • Selected Vaccination Programme Among Children Under 1 Year, 1990-2004 (%)
  • Selected Vaccination Programme Among Children Aged 1 Year, 1990-2004 (%)
  • Selected Vaccination Programme Among Children Aged 1-4 Years, 1990-2004 (%)
• AIDS
  • AIDS Cases, 1983-2004

CHARTS

• Map of Mexico
• Projected Population, 2006-2011
• Estimated Population by Age Group, 2005 (%)
• Leading Causes of Death, 2004 (%)

MEXICO HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• Healthcare Developments
  • World Bank' s Estimated Disbursements for the Third Basic Healthcare Project, 2002-2007 (US$ Million)
• Social Security
  • Population Coverage by Provider, 2004
  • Insured Population by Provider, 1991-2002
  • Insured Population by Provider as % of Total, 1991-2002
  • Change in Insured Population by Provider, 1991-2002 (%)
• Private Sector
  • Grupo Ángeles' Hospitals, 2004
• HEALTH EXPENDITURE
  • Public & Private Health Expenditure, 2004-2006 (US$ Billion)
  • Public & Private Health Expenditure per Capita, 2004-2006 (US$)
  • Public Health Expenditure by State, 2004 (%)
  • Public Health Expenditure by State and Coverage, 2004 (%)
• HOSPITAL SERVICES
• Hospitals
  • Hospitals, 1980-2004
  • Public Hospitals by Provider & Type, 2004
  • Public Hospitals by Provider & Type, 2003
  • SSA Hospitals by Type, 2000-2003
  • SSA Hospitals by Type, 2000-2003 (%)
  • Private Hospitals by Number of Beds, 2001
  • Private Medical Establishments by Specialty, 2000-2001
• Hospital Beds
  • Hospital Beds, 2000-2004
  • Public Hospital Beds by Provider, 2003-2004
• Hospital Resources & Technical Equipment
  • Selected Public Hospital Resources, 2003
  • Selected Public Hospital Resources, 1990-2000
  • Selected Public Equipment, 2004
  • Selected Public Equipment, 2003
• Hospital Activity
  • Hospital Discharges, 2001-2004
  • Hospital Surgical Procedures, 2001-2004
  • Attended Hospital Births, 2001-2004
  • Public Hospital Discharges by Provider, 1994-2004 (000s)
  • Public Hospital Discharges by Provider as % of Total, 1994-2004
  • Change in Public Hospital Discharges by Provider, 1995-2004 (%)
  • Public Hospital Discharges (by Specialty), Surgical Procedures & Patient Days by State, 2004
  • Public Hospital Diagnostic Treatments, 2003-2004
  • Public Hospital Diagnostic Treatments by State, 2004 (000)
  • Private Hospital Activity by Specialty & Number of Beds, 2003
  • Private Hospital Diagnostic Treatments, 2003
• AMBULATORY CARE
• Outpatient Facilities
  • Public Outpatient Facilities by Provider, 2003
  • Public Outpatient Facilities by Type, 2000-2003
  • Public Outpatient Facilities by State, 2003
  • Consulting Rooms, 2001-2003
  • Public Consulting Rooms by Type, 2001-2003
  • Public Consulting Rooms by Provider, 2003
  • Public Consulting Rooms by State & Provider, 2003
  • Private Consulting Rooms by State & Type, 2001
• Outpatient Consultations
  • Outpatient Consultations, 2000-2004
  • Public Outpatient Consultations by Type, 2000-2004
  • Public Outpatient Consultations by Provider, 2004
  • Public Outpatient Consultations by State, 2004
  • Private Outpatient Consultions by Type, 2000-2003
  • Private Outpatient Consulations by Number of Beds, 2003
• MEDICAL PERSONNEL
  • Doctors & Nurses, 2003
  • Public Human Resources, 2003
  • Public Doctors & Dentists by Specialty, 2003
  • Public Doctors & Dentists by Provider, 2003
  • Public Doctors & Dentists by State, 2003

CHARTS

• Families Affiliated to Seguro Popular by Income Level, 2004
• Public & Private Health Expenditure as a Percentage of GDP, 1993-2004
• Per Capita Health Expenditure per Institution, 2004
• Public Hospitals, 2000-2004
• SESA Hospitals by Bed Size, 2004
• Public Hospital Beds, 2000-2004
• Public Hospital Beds per Thousand Population by Provider, 2004
• SESA Hospital Beds by Specialty, 2003 (%)
• Tomographers by Public Provider, 2003-2004
• Public Doctors & Nurses, 1986-2000 (000)

MEXICO ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• Pharmaceutical Registration
• Drug Approval Process
  • Drug Classifications
  • Import Regulations
• Advertising of Non-Prescription Drugs
• Patent Protection & Intellectual Property Rights
• Pricing and Reimbursement
• DISTRIBUTION CHANNELS
• Distributors
  • Casa Saba
  • Casa Marzam
  • NADRO
• Pharmacy Chains & Independent Pharmacies
  • Members of ANADIM
    • Farmacias Benavides
    • Farmacias Guadalajara
    • Farmacias Similares
• TRADE FAIRS
  • Biofarmacéutica
  • Expo Farma AFM
  • II Expo Feria Médica
  • Expo Médica Hospital
  • Hospimédica Mexico
• DOMESTIC PRODUCTION
  • Gross Pharmaceutical Production, 1999-2004 (Million Pesos & US$ Million)
  • Pharmaceutical Production Indicators by State, 2003
  • Pharmaceutical Production Indicators by State, 2003 (%)
  • Pharmaceutical Production Indicators by Workforce, 2003
  • Pharmaceutical Production Indicators by Workforce, 2003 (%)
  • Pharmaceutical Workforce by Sector, 2003 & 2004
  • Pharmaceutical Workers & Direct Employees, 1999-2004
• Trade Associations
  • AFAMELA
  • AMEGI
• Members of AMEGI, 2006
  • AMIIF
• Members of AMIIF, 2006
  • ANAFAM
• Members of ANAFAM, 2006
  • CANIFARMA
• Members of CANIFARMA, 2006
• Domestic Producers
  • Research-Based Producers
  • The Ten Leading Pharmaceutical Manufacturers, 2003 (US$ Million)
    • Generic Producers
    • Producers of ‘Miracle Products’
    • Armstrong Laboratorios de Mexico
    • AstraZeneca
    • Bayer
    • Boehringer Ingelheim
    • Bristol-Myers Squibb
    • Eli Lilly
    • Genomma Lab
    • GlaxoSmithKline
    • Laboratorios Kendrick
    • Laboratorios Liomont
    • Merck
    • Merck-Sharp & Dohme
    • Novartis
  • Novartis' Sales by Division, 2002
    • Pfizer
    • Probiomed
    • QUIFA
    • Roche
    • Sanofi-Aventis
    • Schering-Plough
    • Silanes
    • Sinbiotik International
    • Solvay Pharmaceuticals
    • Teva
    • Wyeth
• Research & Development
  • Clinical Studies, 2003-2004
• DIRECTORY
  • Government Organisations
  • Trade Associations

CHARTS

• GCS' s Sales, 2000-2004 (Billion Pesos & US$ Billion)
• GCS' s Net Income, 2001-2004 (Million Pesos & US$ Million)
• Farmacias Benavides' Sales, 2000-2004 (Million Pesos & US$ Million)
• Farmacias Guadalajara' s Outlets, 1997-2006
• Gross Pharmaceutical Production, 1999-2004 (Billion Pesos & US$ Billion)
• Pharmaceutical Workers & Direct Employees, 1999-2004 (000s)
• The Ten Leading Pharmaceutical Manufacturers, 2003 (%)
• R&D Investments, 1999-2004 (US$ Million)
• Leading Areas of Investigation by Number of Producers, 2003-2004

TURKEY BACKGROUND DATA

• GEOGRAPHY
  • Map of Turkey
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
  • GDP & Growth, 1995-2006
• POPULATION
  • Population by Region, 2002-2005 (000s)
  • Population by Age, 2005 (000s)
• DEMOGRAPHIC INDICATORS
  • Demographic Indicators, 2000-2004
• MORTALITY
  • Registered Deaths by Type, 1999-2003
• MORBIDITY
  • Notifiable Infectious Diseases, 1999-2004
  • Vaccination Coverage of Children Under One Year of Age, 1999-2004 (%)
• HIV/AIDS
  • AIDS Cases and Carriers by Age and Sex, 1985-2004,
  • AIDS Cases, 1995-2004
  • Reported AIDS Cases, 1982-2003
• Cancer
  • Male Cancer by Site, 1999
  • Female Cancer by Site, 1999
    • Cancer Control Programme
• Diabetes
  • National Diabetes Programme
• Tuberculosis
  • Tuberculosis Cases, 1990-2002

CHARTS

• Population by Age, 2005 (%)

TURKEY HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• Health Insurance
  • Population Coverage, by Insurance Provider, 1999-2000
• HEALTH EXPENDITURE
• HOSPITAL SERVICES
  • Hospital Resources, 2000-2004
  • Hospital Resources by Operator, 2004
• Hospital Activity
  • Hospital Activity Trends, 1998-2004
  • Hospital Discharges by Diagnosis and Sex, 2004
  • Patient Days by Diagnosis and Sex, 2004
  • Inpatient Activity at Ministry of Health Institutions, 2002
  • Hospital Efficiency by Hospital Size, 2000
• AMBULATORY CARE
  • Outpatient Facilities, 1999-2003
  • Visits to Outpatient Facilities by Type of Hospital, 1995-2000
  • Utilisation of Non-Public Hospitals, 2000
• MEDICAL PERSONNEL
  • Physicians by Establishment, 2003
  • Other Medical Personnel by Establishment, 2003

CHARTS

• Hospitals by Operator, 2004 (%)
• Beds by Operator, 2004 (%)
• Outpatient Facilities by Type, 2003 (%)

TURKEY ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
  • OTC Legislation
• Pharmaceutical Registration
  • Section 1: Summary of File
  • Section 2: Chemical, Pharmaceutical and Biological Information
  • Section 3: Toxicological and Pharmacological Information
  • Section 4: Clinical Documentation
  • Generics
• Data Required for Marketing Authorisation in Turkey
  • Post-marketing Surveillance
• Advertising
• Patent Protection & Intellectual Property Rights
• Pricing and Reimbursement
  • Patient Co-payment Policy
  • New Reimbursement System
• DISTRIBUTION CHANNELS
• Distributors
• DOMESTIC PRODUCTION
  • Pharmaceutical Consumption by Therapeutic Class, 1999-2005 (%)
  • Worldwide Top Five Therapeutic Classes (%)
  • Pharmaceutical Production, 1999-2003
  • Investment in the Pharmaceutical Industry, 1992-2002 (US$ million)
• Trade Associations
  • Pharmaceutical Manufacturer' s Association (IEIS)
• Domestic Producers
  • Abdi Ibrahim Ilac Sanyi ve Ticaret A.S
  • Bilim Pharmaceuticals
  • Eczacibasi
  • Embil Pharmaceutical Co. Ltd
  • Fako Ilaçlari A.S
  • Mustafa Nevzat Pharmaceuticals
  • Sanovel
  • Turgut Group
• DIRECTORY
• Government Organisations
• Trade Associations

CHINA BACKGROUND DATA

• Geographic
• Political
• Economic
• Population
  • Population Estimates, 1991-2003
  • Population by Province, December 2003
• Population Growth
• Demographic Indicators
  • Principal Demographic Indicators, 1998-2003
  • Demographic Indicators by Province, 2003
• Mortality
  • Major Causes of Death, 1999
  • Major Causes of Death in Urban Areas, 1999-2002
  • Major Causes of Death in Rural Areas, 1999-2002
• Morbidity
  • Reported Infectious Diseases, 1998-2002 (Rate per 100,000 population)
    • Chronic Diseases
    • HIV/AIDS
    • Tuberculosis
    • Tobacco

CHINA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• Ministry of Health
  • Hospitals
  • Rural Healthcare
  • Health Insurance
  • Rural Co-operative Medical Care System
  • Commercial Medical Insurance
  • Red Cross Society of China
• HEALTH EXPENDITURE
  • Total Health Expenditure, 1995-2002 (Yuan billions)
• HOSPITAL SERVICES
  • Healthcare Facilities
  • Healthcare Institutions by Type, 2000-2003
  • Hospitals by Type, 1998
  • Healthcare Institutions by Type, 2002
  • Healthcare Institutions by Type and Province, 2002
    • Joint venture hospitals
• Hospital Beds
  • Healthcare Beds, 1995-2003 (000s)
  • Number of Beds in Healthcare Institutions by Type, 2000-2002
  • Beds by Region, 2003
  • Hospital Beds by Department, 2000 and 2002 (000s)
    • Military Hospitals
    • Private Hospitals
• Hospital Activity
  • Hospital Admissions, 1999-2003 (millions)
  • Hospital Bed Utilisation Statistics, 1992-2001
  • Bed Occupancy Rates by Type of Hospital, 1992-2001 (%)
  • Bed Turnover & Days in Use by Type of Hospital, 1992-2001
• AMBULATORY CARE
  • Outpatient Facilities, 2000-2003
    • Hospital Outpatient Activity
  • Hospital Outpatient Visits, 1999-2001 (millions)
• MEDICAL PERSONNEL (22-39)
  • Medical Personnel (000s), 2000-2003
  • Middle and High Level Health Professionals, 1995-2001
  • Medical Personnel by Province, 2003
  • Medical Technical Personnel by Type of Institution, 1998 (000s)
  • Number of Doctors by Department, 2000
    • Rural Physician Reforms

CHINA ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
• Pharmaceutical Registration
• State Food and Drug Administration (SFDA)
  • Department of Drug Registration
  • Department of Drug Safety & Inspection
  • Department of Drug Market Compliance
  • Drug Classification
  • Biotech regulation
• New Regulatory Legislation
  • 2001 DAL Amendments
  • The Drug Import Regulation
• GMP Regulations
• Pharmaceutical Registration/Drug Approval Process
  • Clinical trials
  • Quality test
  • Certification
• Packaging Regulations
• Post-market Surveillance
  • Sector Development
• Pharmaceutical Advertising
  • Sector Development
• Patent Protection & Intellectual Property Rights
  • Administrative Protection
• Pharmaceutical Pricing and Reimbursement
  • Pricing
  • Pricing Sector Development
  • Provincial governments
  • Reimbursement Lists
• DISTRIBUTION CHANNELS
  • Distribution System Reform
  • Internet Pharmaceutical Distribution
  • Pharmaceutical retail
• Distributors
  • Chindex
  • Hainan Kangtong Pharmaceutical Co Ltd.
  • Hunan Provincial Medicines & Health Products Import & Export Corp.
  • Shandong Medicines & Health Products Import & Export Corp.
  • Sincer Pharmchem Ltd
  • Sinochem Jiangsu Suzhou Import Export Corp
  • Tianjin Medicines & Health Products Import & Export Corp
• PHARMACEUTICAL IMPORTS
  • Summary Pharmaceutical Imports, 1999-2003 (US$000s)
  • Leading Suppliers of Raw Materials, 2003 (US$000s)
  • Leading Suppliers of Medicaments, 2003 (US$000s)
  • Imports of Pharmaceuticals, 1999-2003 (US$000s)
  • Leading Suppliers, 2003 (U$000s)
  • Leading Suppliers by Category, 2003 (US$000s)
• DOMESTIC PRODUCTION
  • Chinese Medical/Pharmaceutical Production, 2001-02
    • 10th Five Year Plan Targets
    • Zhejiang pharmaceutical investment plans
    • HIV/AIDS drugs
• Domestic Producers
  • Anhui Anke Biotech
  • Beijing Four Ring Pharmaceutical Factory
  • Changzhou Siyao Pharmaceuticals Co. Ltd
  • China Pharmaceutical Enterprise
  • Dragon Pharmaceuticals
  • Dragon Pharmaceutical revenues, 2003-04 (US$ millions)
  • Dragon Pharmaceutical revenues by Segment, Q1 2005 (US$ millions)
    • Fuzhou Antibiotic Group Corp
    • Haizhou Pharmaceutical Co. Ltd
    • Heshuo Ephedrine Factory
    • Huazhong Pharmaceutical Co. Ltd
    • Jiangsu Jiangan Pharmaceutical Corp Ltd
    • Jiuyuan
    • Livzon (Group) Libao Biochemical & Pharmaceutical Co Ltd
    • Ningbo Jierfu Pharmaceutical Co Ltd
    • North China Pharmaceutical Huasheng Co. Ltd
    • Shandong Xinhua Lukang Pharmaceutical Group
    • Shenyang Sunshine Pharmaceutical Co Ltd
    • Shenzhen Kexing Biotech
    • Shenzhen Pharmaceutical Factory
    • Shenzhen Taitai Pharmaceutical Industry (Taitai)
    • Wenzhou Pharmaceutical Factory
    • Xiamen No.2 Pharmaceutical Factory
    • Xi' an Pharmaceutical Factory
    • Yiyuan Pharmaceutical Co Ltd
    • Zhejiang Jinhua Lixin Fine Chemicals Co Ltd
• Multinational Producers
  • Allergan
  • Antibioticos
  • AstraZeneca
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi Pharmaceutical Co. (China)
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson
  • Laboratories Servier
  • Merck KGaA
  • Merck Sharp & Dohme
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Ranbaxy
  • Rexim SA (Degussa)
  • Roche
  • Sankyo
  • Sanofi-Synthèlabo
  • Schering-Plough
  • Takeda
  • Tanabe
  • Valeant Pharmaceuticals
  • Watson
  • Yamanouchi
• Research & Development
  • SFDA initiatives
  • Zhangjiang Hi-Tech Park
  • Beijing Union Pharmaceutical Factory
  • AstraZeneca
• Exports
  • Summary Pharmaceutical Exports, 1999-2003 (US$000s)
  • Exports of Pharmaceuticals 1999-2003
  • Leading Destinations, 2003 (U$000s)
  • Pharmaceutical Balance of Trade, 1999-2003
• DIRECTORY

CHARTS

• Imports of Raw Materials/Retail Medicaments, 1998-2003 (US$000s)
• Leading Suppliers, 2003 (%)
• Exports by Category, 2003 (%)
• Leading Destinations, 2003 (%)

INDONESIA BACKGROUND DATA

• GEOGRAPHY
• Map of Indonesia
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
• POPULATION
  • Population, 1980-2005
  • Population by Province, 2005
• DEMOGRAPHIC INDICATORS
  • Principal Demographic Indicators, 1995-2004
• MORTALITY
  • Top 45 Leading Causes of Deaths in Hospitals, 2004
  • Infant Mortality Rates in Hospitals, 2004
  • Deaths from Conditions Originating from the Perinatal Period, 2004

CHARTS

• Population by Age Group, 2005 (%)

INDONESIA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• HEALTH EXPENDITURE
• Public Expenditure
  • National Health Budget, 1995/96 to 2005
  • Realised Ministry of Health Budget 2005 (Rupiah billions)
• HOSPITAL SERVICES
  • Total Hospitals & Beds, 1995-2004
  • Hospitals and Bed by Province, 2000 & 2004
  • Specialist Hospitals and Beds by Type, 2004
  • General Hospitals & Beds by Sector, 2000-2004
• MORBIDITY
  • Inpatients by Age, 2004
  • Inpatients by Gender, 2004
  • Outpatients by Gender, 2004
  • Distribution of Obstetric Patients by Age, 2004
  • Distribution of Outpatients with Infectious Diseases, 2004
  • Distribution of Inpatients with Infectious Diseases, 2004
  • Distribution of Outpatients, 2004
  • Distribution of Inpatients, 2004
  • Top 10 Categories of Disease of Outpatients, 2004
  • Top 10 Categories of Disease of Inpatients, 2004
  • Top 50 Causes of Outpatient Care, 2004
  • Top 50 Causes for Hospitalisation/Inpatient Care, 2004
  • Top 10 Malignant Neoplasm Outpatient Visits, 2004
  • Top 10 Malignant Neoplasms of Inpatients, 2004
  • Inpatient Distribution of Intestinal and Digestive Neoplasms, 2004
  • Outpatient Distribution of Intestinal and Digestive Neoplasms, 2004
  • Distribution of Inpatients of Malignant Respiratory and Intrathoracic Organs Neoplasms, 2004
  • Outpatient Distribution of Malignant Respiratory and Intrathoracic Organs Neoplasms, 2004
  • Distribution of Inpatients of Malignant Male Genital Organs Neoplasms, 2004
  • Outpatient Distribution of Malignant Male Genital Organs Neoplasms, 2004
  • Distribution of Inpatients of Neoplasms of the Urinary Tract, 2004
  • Outpatient Distribution of Neoplasms of the Urinary Tract, 2004
  • Distribution of Inpatients of Other Malignant Neoplasms by Type, 2004
  • Outpatient Distribution of Other Malignant Neoplasms, 2004
  • Distribution of Inpatients of Carcinoma In Situ, 2004
  • Outpatient Distribution of Carcinoma In Situ, 2004
  • Distribution of Inpatients of Benign Neoplasms, 2004
  • Distribution of Inpatients of External Causes for Morbidity and Mortality, 2004
  • Outpatient Distribution for External Causes for Morbidity and Mortality, 2004
  • Nosocomial Infections in General and Specialist Hospitals, 2004
  • Nosocomial Infections by Province, 2004
  • Nosocomial Infections by Type, 2004
    • HIV/AIDS
    • Bird Flu
• AMBULATORY CARE
  • Outpatient Facilities, 1993-2001
  • Public Health Centres by Province, 1996-2001
• MEDICAL PERSONNEL
  • Medical Personnel, 1997-2004
  • Distribution of Medical Personnel, 2004
  • Distribution of Other Medical Personnel, 2004
  • Distribution of Medical Personnel in Specialist Hospitals, 2004
  • Distribution of Other Medical Personnel in Specialist Hospitals, 2004
  • Distribution of Medical Personnel by Province, 2004

RUSSIA BACKGROUND DATA

• GEOGRAPHY
• POLITICAL OVERVIEW
• ECONOMIC OVERVIEW
• POPULATION
  • Population by Age and Sex, 2005
  • Population by District, 2001
• DEMOGRAPHIC INDICATORS
  • Principal Demographic Indicators, 1995-2004
• MORTALITY
  • Deaths by Cause, 2004
    • Infant Mortality
  • Infant Mortality by Cause, 2004
• MORBIDITY
  • Incidence of Morbidity by Diagnosis, 2000-2004 (000)
• Infectious Diseases
  • Infectious Diseases, 2000-2001
    • Tuberculosis
    • HIV/AIDS

CHARTS

• Map of Russia
• Population, 1989-2005 (millions)
• Population by Age Group, 2005 (%)
• Leading Causes of Death, 2004 (%)

RUSSIA HEALTHCARE SYSTEM

• ORGANISATION & ADMINISTRATION
• HEALTH EXPENDITURE
  • Hospital funding change proposed
• HOSPITAL SERVICES
  • Public Hospitals, 1996-2004
  • Hospital Beds, 1996-2004
• MoH Facilities
  • MOH Inpatient Facilities, 2002-2004
  • Public Hospital Beds by Specialty, 2003-2004
• Hospital Activity
  • Hospital Discharges by Group of Diseases, 2002-2004
  • Hospital Activity, 1998-2004
  • Bed Occupancy (Days) By Type of Hospital, 1999-2001
    • Surgical procedures
  • Surgical Operations In Hospitals, 2003-2004
• AMBULATORY CARE
  • Outpatient Care Facilities, 1996-2004
• MoH Facilities
  • Outpatient Facilities and Polyclinics, 2002-2003
  • Surgical Operations in Polyclinics & Outpatient Units, 2000-2003
  • Surgical Operations in Polyclinics, 2000-2001
• Day Surgery
  • Day Surgeries, 2003-2004
  • Day Surgery Discharges by Group of Diseases, 2003-2004
  • Physician Visits, 2003-2004
• MEDICAL PERSONNEL
  • MoH Medical Personnel, 1997-2004
  • MoH Doctors by Type, 2002-2004
  • MoH Doctors by Leading Specialty, 2002-2004 (000)

RUSSIA ACCESSING THE PHARMACEUTICAL MARKET

• INTRODUCTION
• REGULATORY ENVIRONMENT
  • VAT on Pharmaceuticals
• Pharmaceutical Registration
• Import Regulations
• Advertising
• Patent Protection & Intellectual Property Rights
  • Counterfeit Medicines
• Pricing and Reimbursement
  • Drug Pricing
  • Reimbursement
• DISTRIBUTION CHANNELS
• Distributors
  • Protek
  • Shreya Corporation
  • SIA International
• TRADE FAIRS
  • Hospital
  • Pharmtech 2006
• DOMESTIC PRODUCTION
  • Top Ten Domestic Producers, November 2005 (US$ millions)
  • Russian Pharmaceutical Output, 2000-2003 (US$ millions)
• Trade Associations
  • AIPM
• Domestic Producers
  • Akrikhin
  • Bryntsalov A
  • JSC Farmacon
• ICN Russia Sales, 1999-2003 (US$ millions)
  • KRKA
  • Nizhpharm
• Nizhpharm Sales, 1999-2003
  • Otechestvennye Lekarstva (Erka Farm)
  • Veropharm
  • Yugrafarm
• Multinationals
  • Top Ten Multinationals by Sales, 2003-2004 (%)
• Research & Development
• DIRECTORY
• Government Organisations
• Regional Health Authorities
• Trade Associations